Search
Now showing items 1-8 of 8
Microfluidic technologies for genomic interrogation of mycobacterium tuberculosis clinical isolates using the polymerase chain reaction (PCR) and high resolution melting analysis (HRMA).
(2015)
Background: A number of Mycobacterium tuberculosis (Mtb) genes have been shown to be under positive selection pressure in the presence of anti-TB therapy. This results in the selection of drug resistant phenotypes associated ...
Light forge : a microfluidic high throughput platform for rapid and affordable detection of drug resistant strains of tuberculosis.
(2015)
Tuberculosis is one of the most deadly infectious diseases currently plaguing the global community. Unfortunately, lack of accessible, reliable and affordable diagnostic tools in the high disease burden, and resource poor ...
Investigating the effect of sex hormones on the immune response to TB and HIV.
(2015)
Background:
Global incidence rates for tuberculosis (TB) indicate a gender-bias to the disease, with almost twice as
many men actively infected than women (male/female ratio of 1.9). Sex hormones are known to regulate
immune ...
Technologies for a user-friendly microfluidic system for portable applications.
(2015)
In the same way that the HIV virus subdues the human immune system, the HIV/AIDS epidemic has severely overloaded the health service infrastructure in resource limited countries and threatens to systematically suppress ...
Microfluidic technologies for capturing and concentrating human immunodeficiency virus-1 (HIV-1) particles.
(2016)
HIV-1 RNA assays are routinely used in developed countries to monitor the effectiveness of antiretroviral therapy (ART). These assays require well-trained operators, expensive equipment and reagents, and established ...
Drug susceptibility testing of second and third line anti-tuberculosis drugs used in the management of extensively drug resistant tuberculosis.
(2013)
Drug resistant tuberculosis is a major contributor to South Africa’s quadruple burden of
disease. Management of this infection in a highly HIV endemic area is a constant challenge.
There is a paucity of new anti-tuberculosis ...
Antimicrobial properties of traditional medicine used for treatment of HIV/AIDS and its opportunistic infections.
(2012)
This study was conducted to establish the scientific basis of the reported ethnomedicinal use of
Ihlamvu laseAfrika (IHL) against Human Immunodeficiency Virus (HIV) and Acquired
Immunodeficiency Virus (AIDS) related ...
Differences in the susceptibility of mycobacterium tuberculosis to the 1st and 2nd line antituberculosis drugs under aerobic and anaerobic conditions.
(2015)
Although Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is now considered a facultative anaerobe, and bacilli isolated from sputum specimen possess morphologies identified from bacilli growing ...